Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuangQi Decoction in Early Stage Diabetic Kidney Disease
NCT03681704Phase 1Completed
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Nov 2018
- Primary completion
- Dec 2021
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in diabetic kidney disease (DKD) comparing HuangQi Decoction with Placebo (2 arms). Primary endpoint: Albumin-to-Creatinine Ratio at 24 weeks. Started Nov 2018; status: completed.
02
Drugs
huangqi decoction
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT03681704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03681704.